Clayton Chong

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

C. Logothetis, Douglas E. Johnson, Clayton Chong et al. · Journal of Clinical Oncology · 1988 · 164 citations

Medicine, Oncology, Surgery +17

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

Henry M. Kuerer, Benjamin D. Smith, Savitri Krishnamurthy et al. · The Lancet Oncology · 2022 · 161 citations

Medicine, Oncology, Surgery +11

Genetic Abnormalities in Men with Germ Cell Tumors

Francisco H. Dexeus, Christopher J. Logothetis, Clayton Chong et al. · The Journal of Urology · 1988 · 149 citations

Life Sciences, Genetics, Oncology +10

Cisplatin, Cyclophosphamide and Doxorubicin Chemotherapy for Unresectable Urothelial Tumors: The M. D. Anderson Experience

Christopher J. Logothetis, Francisco H. Dexeus, Clayton Chong et al. · The Journal of Urology · 1989 · 101 citations

Medicine, Oncology, Pharmacology +13

Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.

Christopher J. Logothetis, David A. Swanson, F. H. Dexeus et al. · Journal of Clinical Oncology · 1987 · 80 citations

Medicine, Oncology, Chemotherapy +16